Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
5.50
+0.01 (0.18%)
At close: Feb 26, 2026, 4:00 PM EST
5.55
+0.05 (0.91%)
After-hours: Feb 26, 2026, 7:06 PM EST
Aldeyra Therapeutics Market Cap
Aldeyra Therapeutics has a market cap or net worth of $330.9 million as of February 26, 2026. Its market cap has decreased by -7.23% in one year.
Market Cap
330.90M
Enterprise Value
271.14M
1-Year Change
-7.23%
Ranking
Category
Stock Price
$5.50
Market Cap Chart
Since May 2, 2014, Aldeyra Therapeutics's market cap has increased from $37.20M to $330.90M, an increase of 789.50%. That is a compound annual growth rate of 20.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 330.30M | 6.00% |
| Dec 31, 2025 | 311.60M | 4.85% |
| Dec 31, 2024 | 297.20M | 43.92% |
| Dec 29, 2023 | 206.50M | -49.34% |
| Dec 30, 2022 | 407.60M | 75.39% |
| Dec 31, 2021 | 232.40M | -12.73% |
| Dec 31, 2020 | 266.30M | 63.98% |
| Dec 31, 2019 | 162.40M | -25.44% |
| Dec 31, 2018 | 217.80M | 67.54% |
| Dec 29, 2017 | 130.00M | 93.16% |
| Dec 30, 2016 | 67.30M | 2.12% |
| Dec 31, 2015 | 65.90M | 63.93% |
| Dec 31, 2014 | 40.20M | 8.06% |
| May 2, 2014 | 37.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 332.16M |
| Immuneering | 329.31M |
| ALX Oncology Holdings | 321.43M |
| Sutro Biopharma | 320.71M |
| Cabaletta Bio | 316.71M |
| Larimar Therapeutics | 315.83M |
| Relmada Therapeutics | 312.40M |
| Fennec Pharmaceuticals | 304.31M |